{"rating_data": {"avg_stars": 0, "total": 0, "avg": 0}, "name": "OASIS: web-based platform for exploring cancer multi-omics data", "created": "2016-03-03 23:51:47", "url": "http://www.oasis-genomics.org/martreport/?report=report&mart=gene_report&ensembl_gene_id={{ensemblgene}}", "lastmodified": "2016-03-03 23:51:47", "usage_data": {"layouts": 4.0, "users": 3}, "popularity": 4.0, "owner": {"username": "cwu", "url": "/profile/2/cwu", "name": "Chunlei Wu"}, "species": ["human"], "shortUrl": "www.oasis-genomics.org", "id": 1216, "short_description": "OASIS is a web-based platform for exploring cancer multi-omics data, made by Pfizer", "role_permission": ["biogpsusers"], "permission_style": "public", "type": "iframe", "options": null, "tags": ["cancer", "ccle", "cosmic", "expression", "genomics", "tcga"], "description": "OASIS is an open-access web portal that enables cancer researchers to perform exploratory and integrative analyses of somatic mutation, copy number changes (CNV) and gene expression data from thousands of tumor, normal tissues and cell lines representing a broad spectrum of malignancies.\n\nOASIS is developed by Pfizer Oncology Research Computational Biology in collaboration with Research Business Technology (RBT).\n\nReference: http://www.ncbi.nlm.nih.gov/pubmed/26716558"}